长城医药产业精选混合发起式A(022286)申购赎回 |
|
|
| 报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
| 2026/3/31 |
233,534,000 |
233,974,000 |
65,692,500 |
65,251,600 |
440,900 |
0.19% |
| 2025/12/31 |
9,171,320 |
233,534,000 |
653,614,000 |
429,252,000 |
224,362,000 |
2446.34% |
| 2025/12/31 |
196,780,000 |
233,534,000 |
117,086,000 |
80,332,600 |
36,753,400 |
18.68% |
| 2025/9/30 |
122,101,000 |
196,780,000 |
312,641,000 |
237,961,000 |
74,680,000 |
61.16% |
| 2025/6/30 |
9,171,320 |
122,101,000 |
223,887,000 |
110,958,000 |
112,929,000 |
1231.33% |
| 2025/6/30 |
16,040,800 |
122,101,000 |
216,679,000 |
110,619,000 |
106,060,000 |
661.19% |
| 2025/3/31 |
9,171,320 |
16,040,800 |
7,208,220 |
338,734 |
6,869,486 |
74.9% |
| 2024/12/31 |
9,170,310 |
9,171,320 |
15,293 |
14,283 |
1,010 |
0.01% |
| 2024/12/31 |
9,170,310 |
9,171,320 |
15,293 |
14,283 |
1,010 |
0.01% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。